Lilly Kong is currently the VP of Research and Development at Bako Diagnostics, a position held since 2021. Prior to this role, Lilly served as Principal at Kong Consulting International from 2017 to 2021 and held various leadership positions at Quest Diagnostics from 1989 to 2009, including VP of Research and Development. Lilly’s experience also includes serving as CSO at PrimeraDx from 2009 to 2014 and as Sr. Director of Assay Development at Qiagen from 2014 to 2016. They are currently pursuing a DVM in Veterinary Medicine at National Taiwan University and previously earned an MS in Veterinary Microbiology from Auburn University and completed a Postdoc in Retrovirology at the University of Alabama at Birmingham.
This person is not in any teams
This person is not in any offices